MedStar Georgetown University Hospital — Washington D.C., District of Columbia

Public research footprint of MedStar Georgetown University Hospital, compiled from the ClinicalTrials.gov public registry.

505

Registered studies

226

Active

Recruiting now

203

Completed

Stopped or withdrawn

Most-studied conditions

Metastatic Bladder Large Cell Neuroendocrine Carcinoma · Locally Advanced Malignant Solid Neoplasm · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Lung Non-Small Cell Carcinoma

Recently updated registry entries

NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT07742735 — A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at MedStar Georgetown University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.